BMY FY 2009 Earnings — Bristol-Myers Squibb Company Revenue & Financial Results | Market Cap Arena

BMYBristol-Myers Squibb Company

$120B

FY 2009 Earnings

Healthcare Drug Manufacturers - General

Income Statement

Revenue

$18.8B-8.7% YoY

Gross Profit

$13.8B73.3% margin

Operating Income

$5.0B26.8% margin

Net Income

$10.6B56.4% margin

EPS (Diluted)

$5.37

Cash Flow

Operating Cash Flow

$4.1B

Free Cash Flow

$3.3B

Stock-Based Comp.

$183M

Balance Sheet

Total Assets

$31.0B

Total Liabilities

$16.2B

Stockholders' Equity

$14.8B

Cash & Equivalents

$7.7B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$18.8B	$20.6B	-8.7%
Gross Profit	$13.8B	$14.4B	-4.6%
Operating Income	$5.0B	$4.9B	+3.5%
Net Income	$10.6B	$5.2B	+102.2%